[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dihydrocodeine Market, Global Outlook and Forecast 2022-2028

March 2022 | 114 pages | ID: D8B8E7C0ACE6EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) (as in co-dydramol) or aspirin.

This report contains market size and forecasts of Dihydrocodeine in global, including the following market information:

Global Dihydrocodeine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Dihydrocodeine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Dihydrocodeine companies in 2021 (%)

The global Dihydrocodeine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dihydrocodeine include AHPL, Teofarma, Mundipharma, Napp Pharmaceuticals, Aspen Pharmacare, Martindale-Hubbell, Duopharma Biotech Berhad, Wockhardt and Auden Mckenzie Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dihydrocodeine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dihydrocodeine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dihydrocodeine Market Segment Percentages, by Type, 2021 (%)
  • Oral
  • Injection
Global Dihydrocodeine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dihydrocodeine Market Segment Percentages, by Application, 2021 (%)
  • Cough Suppressant
  • Analgesic
Global Dihydrocodeine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dihydrocodeine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dihydrocodeine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Dihydrocodeine revenues share in global market, 2021 (%)

Key companies Dihydrocodeine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Dihydrocodeine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • AHPL
  • Teofarma
  • Mundipharma
  • Napp Pharmaceuticals
  • Aspen Pharmacare
  • Martindale-Hubbell
  • Duopharma Biotech Berhad
  • Wockhardt
  • Auden Mckenzie Pharma
  • WraSer
  • GlaxoSmithKline
  • G.L. Pharma
  • Daiichi Sankyo
  • Fuso Pharmaceutical
  • Nichi-Iko Pharmaceutical
  • Takata Pharmaceutical
  • Toyo Seikan Group
  • Teva
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dihydrocodeine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dihydrocodeine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIHYDROCODEINE OVERALL MARKET SIZE

2.1 Global Dihydrocodeine Market Size: 2021 VS 2028
2.2 Global Dihydrocodeine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dihydrocodeine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Dihydrocodeine Players in Global Market
3.2 Top Global Dihydrocodeine Companies Ranked by Revenue
3.3 Global Dihydrocodeine Revenue by Companies
3.4 Global Dihydrocodeine Sales by Companies
3.5 Global Dihydrocodeine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dihydrocodeine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dihydrocodeine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dihydrocodeine Players in Global Market
  3.8.1 List of Global Tier 1 Dihydrocodeine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Dihydrocodeine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dihydrocodeine Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Injection
4.2 By Type - Global Dihydrocodeine Revenue & Forecasts
  4.2.1 By Type - Global Dihydrocodeine Revenue, 2017-2022
  4.2.2 By Type - Global Dihydrocodeine Revenue, 2023-2028
  4.2.3 By Type - Global Dihydrocodeine Revenue Market Share, 2017-2028
4.3 By Type - Global Dihydrocodeine Sales & Forecasts
  4.3.1 By Type - Global Dihydrocodeine Sales, 2017-2022
  4.3.2 By Type - Global Dihydrocodeine Sales, 2023-2028
  4.3.3 By Type - Global Dihydrocodeine Sales Market Share, 2017-2028
4.4 By Type - Global Dihydrocodeine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dihydrocodeine Market Size, 2021 & 2028
  5.1.2 Cough Suppressant
  5.1.3 Analgesic
5.2 By Application - Global Dihydrocodeine Revenue & Forecasts
  5.2.1 By Application - Global Dihydrocodeine Revenue, 2017-2022
  5.2.2 By Application - Global Dihydrocodeine Revenue, 2023-2028
  5.2.3 By Application - Global Dihydrocodeine Revenue Market Share, 2017-2028
5.3 By Application - Global Dihydrocodeine Sales & Forecasts
  5.3.1 By Application - Global Dihydrocodeine Sales, 2017-2022
  5.3.2 By Application - Global Dihydrocodeine Sales, 2023-2028
  5.3.3 By Application - Global Dihydrocodeine Sales Market Share, 2017-2028
5.4 By Application - Global Dihydrocodeine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dihydrocodeine Market Size, 2021 & 2028
6.2 By Region - Global Dihydrocodeine Revenue & Forecasts
  6.2.1 By Region - Global Dihydrocodeine Revenue, 2017-2022
  6.2.2 By Region - Global Dihydrocodeine Revenue, 2023-2028
  6.2.3 By Region - Global Dihydrocodeine Revenue Market Share, 2017-2028
6.3 By Region - Global Dihydrocodeine Sales & Forecasts
  6.3.1 By Region - Global Dihydrocodeine Sales, 2017-2022
  6.3.2 By Region - Global Dihydrocodeine Sales, 2023-2028
  6.3.3 By Region - Global Dihydrocodeine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Dihydrocodeine Revenue, 2017-2028
  6.4.2 By Country - North America Dihydrocodeine Sales, 2017-2028
  6.4.3 US Dihydrocodeine Market Size, 2017-2028
  6.4.4 Canada Dihydrocodeine Market Size, 2017-2028
  6.4.5 Mexico Dihydrocodeine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Dihydrocodeine Revenue, 2017-2028
  6.5.2 By Country - Europe Dihydrocodeine Sales, 2017-2028
  6.5.3 Germany Dihydrocodeine Market Size, 2017-2028
  6.5.4 France Dihydrocodeine Market Size, 2017-2028
  6.5.5 U.K. Dihydrocodeine Market Size, 2017-2028
  6.5.6 Italy Dihydrocodeine Market Size, 2017-2028
  6.5.7 Russia Dihydrocodeine Market Size, 2017-2028
  6.5.8 Nordic Countries Dihydrocodeine Market Size, 2017-2028
  6.5.9 Benelux Dihydrocodeine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Dihydrocodeine Revenue, 2017-2028
  6.6.2 By Region - Asia Dihydrocodeine Sales, 2017-2028
  6.6.3 China Dihydrocodeine Market Size, 2017-2028
  6.6.4 Japan Dihydrocodeine Market Size, 2017-2028
  6.6.5 South Korea Dihydrocodeine Market Size, 2017-2028
  6.6.6 Southeast Asia Dihydrocodeine Market Size, 2017-2028
  6.6.7 India Dihydrocodeine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Dihydrocodeine Revenue, 2017-2028
  6.7.2 By Country - South America Dihydrocodeine Sales, 2017-2028
  6.7.3 Brazil Dihydrocodeine Market Size, 2017-2028
  6.7.4 Argentina Dihydrocodeine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Dihydrocodeine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Dihydrocodeine Sales, 2017-2028
  6.8.3 Turkey Dihydrocodeine Market Size, 2017-2028
  6.8.4 Israel Dihydrocodeine Market Size, 2017-2028
  6.8.5 Saudi Arabia Dihydrocodeine Market Size, 2017-2028
  6.8.6 UAE Dihydrocodeine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AHPL
  7.1.1 AHPL Corporate Summary
  7.1.2 AHPL Business Overview
  7.1.3 AHPL Dihydrocodeine Major Product Offerings
  7.1.4 AHPL Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.1.5 AHPL Key News
7.2 Teofarma
  7.2.1 Teofarma Corporate Summary
  7.2.2 Teofarma Business Overview
  7.2.3 Teofarma Dihydrocodeine Major Product Offerings
  7.2.4 Teofarma Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.2.5 Teofarma Key News
7.3 Mundipharma
  7.3.1 Mundipharma Corporate Summary
  7.3.2 Mundipharma Business Overview
  7.3.3 Mundipharma Dihydrocodeine Major Product Offerings
  7.3.4 Mundipharma Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.3.5 Mundipharma Key News
7.4 Napp Pharmaceuticals
  7.4.1 Napp Pharmaceuticals Corporate Summary
  7.4.2 Napp Pharmaceuticals Business Overview
  7.4.3 Napp Pharmaceuticals Dihydrocodeine Major Product Offerings
  7.4.4 Napp Pharmaceuticals Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.4.5 Napp Pharmaceuticals Key News
7.5 Aspen Pharmacare
  7.5.1 Aspen Pharmacare Corporate Summary
  7.5.2 Aspen Pharmacare Business Overview
  7.5.3 Aspen Pharmacare Dihydrocodeine Major Product Offerings
  7.5.4 Aspen Pharmacare Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.5.5 Aspen Pharmacare Key News
7.6 Martindale-Hubbell
  7.6.1 Martindale-Hubbell Corporate Summary
  7.6.2 Martindale-Hubbell Business Overview
  7.6.3 Martindale-Hubbell Dihydrocodeine Major Product Offerings
  7.6.4 Martindale-Hubbell Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.6.5 Martindale-Hubbell Key News
7.7 Duopharma Biotech Berhad
  7.7.1 Duopharma Biotech Berhad Corporate Summary
  7.7.2 Duopharma Biotech Berhad Business Overview
  7.7.3 Duopharma Biotech Berhad Dihydrocodeine Major Product Offerings
  7.7.4 Duopharma Biotech Berhad Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.7.5 Duopharma Biotech Berhad Key News
7.8 Wockhardt
  7.8.1 Wockhardt Corporate Summary
  7.8.2 Wockhardt Business Overview
  7.8.3 Wockhardt Dihydrocodeine Major Product Offerings
  7.8.4 Wockhardt Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.8.5 Wockhardt Key News
7.9 Auden Mckenzie Pharma
  7.9.1 Auden Mckenzie Pharma Corporate Summary
  7.9.2 Auden Mckenzie Pharma Business Overview
  7.9.3 Auden Mckenzie Pharma Dihydrocodeine Major Product Offerings
  7.9.4 Auden Mckenzie Pharma Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.9.5 Auden Mckenzie Pharma Key News
7.10 WraSer
  7.10.1 WraSer Corporate Summary
  7.10.2 WraSer Business Overview
  7.10.3 WraSer Dihydrocodeine Major Product Offerings
  7.10.4 WraSer Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.10.5 WraSer Key News
7.11 GlaxoSmithKline
  7.11.1 GlaxoSmithKline Corporate Summary
  7.11.2 GlaxoSmithKline Dihydrocodeine Business Overview
  7.11.3 GlaxoSmithKline Dihydrocodeine Major Product Offerings
  7.11.4 GlaxoSmithKline Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.11.5 GlaxoSmithKline Key News
7.12 G.L. Pharma
  7.12.1 G.L. Pharma Corporate Summary
  7.12.2 G.L. Pharma Dihydrocodeine Business Overview
  7.12.3 G.L. Pharma Dihydrocodeine Major Product Offerings
  7.12.4 G.L. Pharma Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.12.5 G.L. Pharma Key News
7.13 Daiichi Sankyo
  7.13.1 Daiichi Sankyo Corporate Summary
  7.13.2 Daiichi Sankyo Dihydrocodeine Business Overview
  7.13.3 Daiichi Sankyo Dihydrocodeine Major Product Offerings
  7.13.4 Daiichi Sankyo Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.13.5 Daiichi Sankyo Key News
7.14 Fuso Pharmaceutical
  7.14.1 Fuso Pharmaceutical Corporate Summary
  7.14.2 Fuso Pharmaceutical Business Overview
  7.14.3 Fuso Pharmaceutical Dihydrocodeine Major Product Offerings
  7.14.4 Fuso Pharmaceutical Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.14.5 Fuso Pharmaceutical Key News
7.15 Nichi-Iko Pharmaceutical
  7.15.1 Nichi-Iko Pharmaceutical Corporate Summary
  7.15.2 Nichi-Iko Pharmaceutical Business Overview
  7.15.3 Nichi-Iko Pharmaceutical Dihydrocodeine Major Product Offerings
  7.15.4 Nichi-Iko Pharmaceutical Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.15.5 Nichi-Iko Pharmaceutical Key News
7.16 Takata Pharmaceutical
  7.16.1 Takata Pharmaceutical Corporate Summary
  7.16.2 Takata Pharmaceutical Business Overview
  7.16.3 Takata Pharmaceutical Dihydrocodeine Major Product Offerings
  7.16.4 Takata Pharmaceutical Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.16.5 Takata Pharmaceutical Key News
7.17 Toyo Seikan Group
  7.17.1 Toyo Seikan Group Corporate Summary
  7.17.2 Toyo Seikan Group Business Overview
  7.17.3 Toyo Seikan Group Dihydrocodeine Major Product Offerings
  7.17.4 Toyo Seikan Group Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.17.5 Toyo Seikan Group Key News
7.18 Teva
  7.18.1 Teva Corporate Summary
  7.18.2 Teva Business Overview
  7.18.3 Teva Dihydrocodeine Major Product Offerings
  7.18.4 Teva Dihydrocodeine Sales and Revenue in Global (2017-2022)
  7.18.5 Teva Key News

8 GLOBAL DIHYDROCODEINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Dihydrocodeine Production Capacity, 2017-2028
8.2 Dihydrocodeine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dihydrocodeine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 DIHYDROCODEINE SUPPLY CHAIN ANALYSIS

10.1 Dihydrocodeine Industry Value Chain
10.2 Dihydrocodeine Upstream Market
10.3 Dihydrocodeine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Dihydrocodeine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Dihydrocodeine in Global Market
Table 2. Top Dihydrocodeine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Dihydrocodeine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Dihydrocodeine Revenue Share by Companies, 2017-2022
Table 5. Global Dihydrocodeine Sales by Companies, (K Units), 2017-2022
Table 6. Global Dihydrocodeine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Dihydrocodeine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Dihydrocodeine Product Type
Table 9. List of Global Tier 1 Dihydrocodeine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dihydrocodeine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dihydrocodeine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Dihydrocodeine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Dihydrocodeine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Dihydrocodeine Sales (K Units), 2017-2022
Table 15. By Type - Global Dihydrocodeine Sales (K Units), 2023-2028
Table 16. By Application – Global Dihydrocodeine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Dihydrocodeine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Dihydrocodeine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Dihydrocodeine Sales (K Units), 2017-2022
Table 20. By Application - Global Dihydrocodeine Sales (K Units), 2023-2028
Table 21. By Region – Global Dihydrocodeine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Dihydrocodeine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Dihydrocodeine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Dihydrocodeine Sales (K Units), 2017-2022
Table 25. By Region - Global Dihydrocodeine Sales (K Units), 2023-2028
Table 26. By Country - North America Dihydrocodeine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Dihydrocodeine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Dihydrocodeine Sales, (K Units), 2017-2022
Table 29. By Country - North America Dihydrocodeine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Dihydrocodeine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Dihydrocodeine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Dihydrocodeine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Dihydrocodeine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Dihydrocodeine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Dihydrocodeine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Dihydrocodeine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Dihydrocodeine Sales, (K Units), 2023-2028
Table 38. By Country - South America Dihydrocodeine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Dihydrocodeine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Dihydrocodeine Sales, (K Units), 2017-2022
Table 41. By Country - South America Dihydrocodeine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Dihydrocodeine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Dihydrocodeine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Dihydrocodeine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Dihydrocodeine Sales, (K Units), 2023-2028
Table 46. AHPL Corporate Summary
Table 47. AHPL Dihydrocodeine Product Offerings
Table 48. AHPL Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Teofarma Corporate Summary
Table 50. Teofarma Dihydrocodeine Product Offerings
Table 51. Teofarma Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Mundipharma Corporate Summary
Table 53. Mundipharma Dihydrocodeine Product Offerings
Table 54. Mundipharma Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Napp Pharmaceuticals Corporate Summary
Table 56. Napp Pharmaceuticals Dihydrocodeine Product Offerings
Table 57. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Aspen Pharmacare Corporate Summary
Table 59. Aspen Pharmacare Dihydrocodeine Product Offerings
Table 60. Aspen Pharmacare Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Martindale-Hubbell Corporate Summary
Table 62. Martindale-Hubbell Dihydrocodeine Product Offerings
Table 63. Martindale-Hubbell Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Duopharma Biotech Berhad Corporate Summary
Table 65. Duopharma Biotech Berhad Dihydrocodeine Product Offerings
Table 66. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Wockhardt Corporate Summary
Table 68. Wockhardt Dihydrocodeine Product Offerings
Table 69. Wockhardt Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Auden Mckenzie Pharma Corporate Summary
Table 71. Auden Mckenzie Pharma Dihydrocodeine Product Offerings
Table 72. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. WraSer Corporate Summary
Table 74. WraSer Dihydrocodeine Product Offerings
Table 75. WraSer Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. GlaxoSmithKline Corporate Summary
Table 77. GlaxoSmithKline Dihydrocodeine Product Offerings
Table 78. GlaxoSmithKline Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. G.L. Pharma Corporate Summary
Table 80. G.L. Pharma Dihydrocodeine Product Offerings
Table 81. G.L. Pharma Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Daiichi Sankyo Corporate Summary
Table 83. Daiichi Sankyo Dihydrocodeine Product Offerings
Table 84. Daiichi Sankyo Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Fuso Pharmaceutical Corporate Summary
Table 86. Fuso Pharmaceutical Dihydrocodeine Product Offerings
Table 87. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Nichi-Iko Pharmaceutical Corporate Summary
Table 89. Nichi-Iko Pharmaceutical Dihydrocodeine Product Offerings
Table 90. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Takata Pharmaceutical Corporate Summary
Table 92. Takata Pharmaceutical Dihydrocodeine Product Offerings
Table 93. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. Toyo Seikan Group Corporate Summary
Table 95. Toyo Seikan Group Dihydrocodeine Product Offerings
Table 96. Toyo Seikan Group Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. Teva Corporate Summary
Table 98. Teva Dihydrocodeine Product Offerings
Table 99. Teva Dihydrocodeine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. Dihydrocodeine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 101. Global Dihydrocodeine Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Dihydrocodeine Production by Region, 2017-2022 (K Units)
Table 103. Global Dihydrocodeine Production by Region, 2023-2028 (K Units)
Table 104. Dihydrocodeine Market Opportunities & Trends in Global Market
Table 105. Dihydrocodeine Market Drivers in Global Market
Table 106. Dihydrocodeine Market Restraints in Global Market
Table 107. Dihydrocodeine Raw Materials
Table 108. Dihydrocodeine Raw Materials Suppliers in Global Market
Table 109. Typical Dihydrocodeine Downstream
Table 110. Dihydrocodeine Downstream Clients in Global Market
Table 111. Dihydrocodeine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Dihydrocodeine Segment by Type
Figure 2. Dihydrocodeine Segment by Application
Figure 3. Global Dihydrocodeine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dihydrocodeine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dihydrocodeine Revenue, 2017-2028 (US$, Mn)
Figure 7. Dihydrocodeine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dihydrocodeine Revenue in 2021
Figure 9. By Type - Global Dihydrocodeine Sales Market Share, 2017-2028
Figure 10. By Type - Global Dihydrocodeine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Dihydrocodeine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Dihydrocodeine Sales Market Share, 2017-2028
Figure 13. By Application - Global Dihydrocodeine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Dihydrocodeine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Dihydrocodeine Sales Market Share, 2017-2028
Figure 16. By Region - Global Dihydrocodeine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Dihydrocodeine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Dihydrocodeine Sales Market Share, 2017-2028
Figure 19. US Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Dihydrocodeine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Dihydrocodeine Sales Market Share, 2017-2028
Figure 24. Germany Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 25. France Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Dihydrocodeine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Dihydrocodeine Sales Market Share, 2017-2028
Figure 33. China Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 37. India Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Dihydrocodeine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Dihydrocodeine Sales Market Share, 2017-2028
Figure 40. Brazil Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Dihydrocodeine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Dihydrocodeine Sales Market Share, 2017-2028
Figure 44. Turkey Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Dihydrocodeine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Dihydrocodeine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Dihydrocodeine by Region, 2021 VS 2028
Figure 50. Dihydrocodeine Industry Value Chain
Figure 51. Marketing Channels


More Publications